A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 269
Comprehensive Pages
- 8
Geographic and Economic Breakouts
- 5
Year Market Forecasts
- 52
Diseases Analyzed
2025 Cornea Products Market Report: Global Analysis for 2024 to 2030, December, 2025
The “2025 Cornea Products Market Report” delivers an in-depth analysis of the global cornea market, highlighting the latest advances in transplantation, crosslinking, and therapeutic devices aimed at restoring and preserving vision. The report estimates disease prevalence across six major corneal conditions and examines evolving treatment approaches, including cornea transplants, therapeutic lenses, phototherapeutic keratectomy (PTK), intrastromal ring segments, and corneal crosslinking.
It also explores the global ecosystem that supports cornea care—spanning organ donation systems, regulatory environments, and the pivotal roles of cornea specialists, eye banks, and nonprofit organizations.
This 2025 edition evaluates more than 70 products from over 50 companies, with forecasts for unit demand and revenue growth through 2030. It features analysis of emerging pipeline technologies yet to generate revenue and profiles 12 leading market participants shaping the future of cornea treatment.
Latest Industry News & Trends
9/4/2026
BreakingDiagnosticMicroscopesSurgical
Alcon Launches Unity M Ophthalmic Surgical Microscope
Alcon announced Sept. 3 the initial commercial launch of its Unity M ophthalmic surgical microscope. The company said the microscope, which has received CE marking in Europe and regulatory approval...
9/4/2026
BreakingCornealMyopiaRefractive
X-Cel and Essilor Launch Lunara Orthokeratology Lens
X-Cel Specialty Contacts and Essilor Custom Contacts announced Aug. 31 the US launch of Lunara, a new FDA-approved orthokeratology lens. Orthokeratology, or ortho-k, uses specially designed and fit...
9/4/2026
AIBreakingDiagnosticSurgical
AI Replaces Presurgical Scans in Removal of Sight-Threatening Brain Tumor
The European Medical Journal reported Aug. 28 that artificial intelligence had provided real-time guidance for removal of a vision-threatening brain tumor at University College London Hospital (UCL...
9/4/2026
BreakingCataractGlaucomaIOLIndustryPharmaSurgical
SpyGlass Celebrates Grand Opening of New Irvine, California, Headquarters
SpyGlass Pharma celebrated the grand opening of its new Irvine, California, headquarters on Aug. 27, as the company continues to expand. SpyGlass was initially founded in Irvine in 2019 by Malik Y....
9/4/2026
BreakingDiagnosticDry Eye
Ophthalmologist Urges Early Intervention in Dry Eye Management to Avoid Surprises
Jason Bacharach, MD, of North Bay Eye Associates in northern California, has a word of advice for ophthalmologists and optometrists. Four words, actually: interventional dry eye management (IDEM). ...
9/4/2026
Breaking
Basketball Topped US Sports Eye Injuries Treated in 2025, Statistics Show
Basketball had the highest rate of sports-related eye injuries treated in the US in 2025, with 5,236 injuries, according to new statistics published Aug. 26 by Prevent Blindness. The Chicago, Illin...
9/4/2026
AIBreakingDeviceDiagnosticRegulation
US FDA Asks for Feedback on GenAI Medical Device Regulation
The US FDA took inspiration from the way human clinicians are trained in drafting a proposal for the regulation of medical devices that feature generative artificial intelligence (GenAI), and it’s ...
9/4/2026
BreakingDealsRetina
Kiora Licenses Retinal Candidate to Chong Kun Dang for South Korea
Kiora Pharmaceuticals announced Aug. 10 that it had granted Chong Kun Dang (CKD) Pharmaceutical Corp. development and commercialization rights in South Korea to KIO-301 for the treatment of degener...
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.